It was recently shown that deletion of the MR specifically from monocytes and macrophages reduces plaque size and histological markers of inflammation in both the angiotensin II-treated ApoE−/− and the LDL receptor knockout mouse atherosclerosis models, supporting a role for the MR acting in inflammatory cells in atherosclerosis (43). The gene discussed is LDLR; the disease is atherosclerosis.